TIZETATUG REZETECAN
UNII UJR3SD8NLS

Substance Identification & Data

This profile provides standardized clinical and technical data for Tizetatug Rezetecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UJR3SD8NLS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2938864-88-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
UJR3SD8NLS
CAS Registry Number
2938864-88-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TIZETATUG REZETECAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C211811
National Cancer Institute reference terminology for clinical and research data.
INN ID
13287
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tizetatug Rezetecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TIZETATUG REZETECAN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2) (HUMAN-MUS MUSCULUS MONOCLONAL HRP02606 .GAMMA.1-CHAIN), HUMAN-MUS MUSCULUS MONOCLONAL HRP02606 .KAPPA.-CHAIN, DIMER, REDUCED, TETRAKIS(THIOETHER) WITH (2S)-N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)GLYCYLGLYCYL-L-PHENYLALANYL-N-(((1R)-1-CYCLOPROPYL-2-(((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)-2-OXOETHOXY)METHYL)GLYCINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TACSTD2 (TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2, MEMBRANE COMPONENT CHROMOSOME 1 SURFACE MARKER 1, M1S1, GASTROINTESTINAL TUMOR-ASSOCIATED ANTIGEN GA7331, PANCREATIC CARCINOMA MARKER PROTEIN GA733-1, EPITHELIAL GLYCOPROTEIN-1, EGP-1, TROPHOBLAST ANTIGEN-2, CELL SURFACE GLYCOPROTEIN TROP-2, TROP2)), HUMANIZED MONOCLONAL ANTIBODY; CONJUGATED ON AN AVERAGE OF FOUR CYSTEINYL RESIDUES TO REZETECAN
TIZETATUG REZETECAN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus